Transdermal microgels of gentamicin

被引:21
作者
Nnamani, P. O. [1 ,3 ]
Kenechukwu, F. C. [1 ]
Dibua, E. U. [2 ]
Ogbonna, C. C. [2 ,4 ,5 ]
Monemeh, U. L. [1 ]
Attama, A. A. [1 ]
机构
[1] Univ Nigeria, Fac Pharmaceut Sci, Dept Pharmaceut, Drug Delivery Res Unit, Nsukka, Nigeria
[2] Univ Nigeria, Dept Microbiol, Nsukka, Enugu State, Nigeria
[3] Shivaji Univ, Dept Phys, Thin Film Phys Lab, Kolhapur 416004, Maharashtra, India
[4] Univ Camerino, Probiot Res Unit, Microbiol Lab, Sch Biosci & Biotechnol, I-62032 Camerino, MC, Italy
[5] Univ Maryland, Sch Med, Inst Human Virol, Div Epidemiol & Prevent, Baltimore, MD 21201 USA
关键词
Gentamicin; Solid lipid microparticles; Antimicrobial action; Transdermal system; Poloxamer; 407; Polyacrylic acids; DRUG-DELIVERY; SYSTEMS; FORMULATION;
D O I
10.1016/j.ejpb.2012.11.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Phospholipid-modified solid lipid microparticles (SLMs) of Phospholipon(R) 90G and 90H encapsulating the hydrophilic drug, gentamicin were produced and loaded into three polymeric hydrogels of Poloxamer 407 and polyacrylic acids (Carbopols(R) 971P and 974P). The SLMs were characterized by morphology and particle size, drug encapsulation efficiency, thermal properties, pH, and storage stability, whereas the microgels were evaluated for viscosity, spreadability, pH, drug content, and in vitro antimicrobial drug release against five microorganisms (Klebsiella spp., Escherichia coli, Bacillus subtilis, Staphylococcus aureus, and Pseudomonas aeruginosa). Our results generally showed Poloxamer 407 microgels of P90H and P90G as having the most desirable properties in terms of fast antibacterial activity on all tested microorganisms, in vitro diffusion-dependent permeation through rat abdominal skin, spreadability, pH, and viscosity, superior to polyacrylic acids microgels. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:345 / 354
页数:10
相关论文
共 25 条
[1]   Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus:: a time-series analysis [J].
Aldeyab, Mamoon A. ;
Monnet, Dominique L. ;
Maria Lopez-Lozano, Jose ;
Hughes, Carmel M. ;
Scott, Michael G. ;
Kearney, Mary P. ;
Magee, Fidelma A. ;
McElnay, James C. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (03) :593-600
[2]  
Allen LV., 2011, Int J Pharm Compd, V15, P308, DOI DOI 10.1155/2014/215872
[3]  
[Anonymous], CLIN INFECT DIS
[4]   Diclofenac sodium delivery to the eye:: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct [J].
Attama, Anthony A. ;
Reichl, Stephan ;
Mueller-Goymann, Christel C. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 355 (1-2) :307-313
[5]   Current perspectives in dissolution testing of conventional and novel dosage forms [J].
Azarmi, Shirzad ;
Roa, Wilson ;
Lobenberg, Raimar .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 328 (01) :12-21
[6]   INCIDENCE OF AND SIGNIFICANT RISK-FACTORS FOR AMINOGLYCOSIDE-ASSOCIATED NEPHROTOXICITY IN PATIENTS DOSED BY USING INDIVIDUALIZED PHARMACOKINETIC MONITORING [J].
BERTINO, JS ;
BOOKER, LA ;
FRANCK, PA ;
JENKINS, PL ;
FRANCK, KR ;
NAFZIGER, AN .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) :173-179
[7]   Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance [J].
Braem, C. ;
Blaschke, T. ;
Panek-Minkin, G. ;
Herrmann, W. ;
Schlupp, P. ;
Paepenmueller, T. ;
Mueller-Goyman, C. ;
Mehnert, W. ;
Bittl, R. ;
Schaefer-Korting, M. ;
Kramer, K. D. .
JOURNAL OF CONTROLLED RELEASE, 2007, 119 (01) :128-135
[8]  
British Pharmacopoeia, 2009, BRIT PHARM GENT, VII, P2751
[9]   Testosterone solid lipid microparticles for transdermal drug delivery. Formulation and physicochemical characterization [J].
El-Kamel, Amal H. ;
Al-Fagih, Iman M. ;
Alsarra, Ibrahim A. .
JOURNAL OF MICROENCAPSULATION, 2007, 24 (05) :457-475
[10]   Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS) [J].
Friedrich, I ;
Reichl, S ;
Müller-Goymann, CC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 305 (1-2) :167-175